Effect of Systemic Infliximab Therapy in Patients with Sjogren's Syndrome

Creative Commons License

TÜRKOĞLU ŞEN E. B., TUNA S., ALAN S., Arman M. I., Tuna Y., ÜNAL M.

TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, vol.45, no.4, pp.138-141, 2015 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 45 Issue: 4
  • Publication Date: 2015
  • Doi Number: 10.4274/tjo.48379
  • Journal Name: TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.138-141
  • Keywords: Dry eye, infliximab, Sjogren's syndrome, tumor necrosis factor
  • Akdeniz University Affiliated: Yes

Abstract

Objectives: To investigate the effect of systemic infliximab therapy on tear function tests and the ocular surface in patients with Sjogren's syndrome secondary to various autoimmune diseases.